n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and angiotensin ii

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with angiotensin ii in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auguet, M; Chabrier, PE; Zerrouk, A1
Baber, SR; Hyman, AL; Kadowitz, PJ1
Helle, F; Iversen, BM; Vågnes, ØB1
Guo, C; Guo, RW; Liu, H; Qi, F; Wang, XM; Yang, LX; Ye, JS1
Cha, SA; Gao, S; Kim, SH; Park, BM1

Other Studies

5 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and angiotensin ii

ArticleYear
Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:4

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cycloheximide; Cyclooxygenase Inhibitors; Dactinomycin; Endothelium, Vascular; Enzyme Induction; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Synthesis Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Time Factors; Vasoconstrictor Agents

1998
Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cardiac Catheterization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Membrane Proteins; Nitrobenzenes; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Circulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents

2003
Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension.
    American journal of physiology. Renal physiology, 2006, Volume: 291, Issue:1

    Topics: Angiotensin II; Animals; Arterioles; Calcium; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Hypertension, Renovascular; Kidney; Male; Nitrobenzenes; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Regional Blood Flow; RNA, Messenger; Signal Transduction; Sulfonamides

2006
The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2010, Volume: 59, Issue:12

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Basigin; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Imidazoles; Losartan; Macrophages; Nitrobenzenes; Pyridines; Receptor, Angiotensin, Type 1; Signal Transduction; Sulfonamides

2010
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
    Peptides, 2015, Volume: 69

    Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypertension, Renovascular; Natriuretic Peptide, Brain; Nitrobenzenes; Rats; Sulfonamides

2015